RA
GHDX

Ramius Advisors’s Genomic Health, Inc. GHDX Stock Holding History

Ramius Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-430,490
Closed -$29.2M – 86
2019
Q3 		$29.2M Buy
+430,490
New +$29.6M 6.86% 4

Ramius Advisors's GHDX Position: Q4 2019 in Review

Ramius Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 430,490 shares — an estimated $29.2M sold.

Ramius Advisors first reported a position in GHDX in Q3 2019 and held it in 1 quarter. The position peaked at $29.2M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Ramius Advisors reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Ramius Advisors sold 430,490 Genomic Health, Inc. shares in Q4 2019, an estimated $29.2M.
  • Ramius Advisors first reported a position in Genomic Health, Inc. in Q3 2019 and held it in 1 quarter.
  • Ramius Advisors's Genomic Health, Inc. position peaked at $29.2M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Ramius Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.